3
* Plan involves up to $2 billion in one-time restructuring charges * AstraZeneca gives no detail on whether plan involves job cuts * Third-quarter sales and profit top analysts' expectations *
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)